由真菌产生的抗癌二次代谢物:潜在和代表性化合物
Carlos García-Estrada1,2,3, Carlos Barreiro3,4,5, Juan F Martín6
1Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24007 León, Spain.
International journal of molecular sciences
|January 10, 2026
概括
菌类是新型抗癌化合物的丰富来源,具有多种作用机制,为癌症治疗中抗药性提供潜在的解决方案.
科学领域:
- 菌类学 菌类学是指菌类学.
- 自然产品化学 自然产品化学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 癌症仍然是全球主要的死亡原因,耐药性需要新的治疗剂.
- 自然来源,特别是真菌,正在越来越多地探索独特的抗癌化合物.
- 菌代谢物表现出不同的化学结构和抗瘤特性.
研究的目的:
- 审查来自真菌来源的潜在抗瘤化合物.
- 讨论主要的真菌衍生抗瘤剂的特性和生物合成.
- 探索围绕真菌帕克利塔塞尔生物合成的科学辩论.
主要方法:
- 关于由真菌衍生的抗瘤化合物的文献综述.
- 分析精选的真菌代谢物的化学结构和生物合成途径.
- 讨论关于真菌抗癌剂的当前研究和科学辩论.
主要成果:
- 菌产生各种各样的二次代谢产物,具有强大的抗瘤活性.
- 代表性的真菌抗瘤化合物包括固醇,先化二甲基和美特类.
- 菌化合物通过各种机制起作用,包括诱导亡和抑制转移.
结论:
- 真菌天然产品是开发新抗癌药物的宝贵储备.
- 这些化合物提供了新的作用机制来打击癌症药物耐药性.
- 对真菌生物合成和化合物表征的进一步研究对于药物开发至关重要.
相关概念视频
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Fungal Phylum Ascomycota
1.0K
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
1.0K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K


